Shares of genedrive plc (LON:GDR – Get Free Report) were up 15.6% during mid-day trading on Tuesday . The stock traded as high as GBX 1.22 and last traded at GBX 1.16. 13,008,386 shares were traded during trading, an increase of 114% from the average daily volume of 6,068,642 shares. The stock had previously closed at GBX 1.
genedrive Stock Performance
The company has a debt-to-equity ratio of -120.48, a current ratio of 0.99 and a quick ratio of 5.52. The company has a market capitalization of £18.56 million, a PE ratio of -1.46 and a beta of 0.99. The stock has a 50-day simple moving average of GBX 1.21 and a 200 day simple moving average of GBX 1.09.
About genedrive
ggenedrive plc is a pharmacogenetic testing company developing and commercialising a low cost, rapid, versatile and simple to use point of need pharmacogenetic platform for the diagnosis of genetic variants. This helps clinicians to quickly access key genetic information that will aid them make the right choices over the right medicine or dosage to use for an effective treatment, particularly important in time-critical emergency care healthcare paradigms. Based in the UK, the Company is at the forefront of Point of Care pharmacogenetic testing in emergency healthcare.
See Also
- Five stocks we like better than genedrive
- System Upgrade: First Internet Bancorp Options Surge
- AI Security Breaches Raise New Risks for Microsoft and Amazon’s Agent Push
- The AI Chip Blockade Is Creating a Shadow Market
- Grab Holdings Stock Forms Bottom After Strong Beat-and-Raise Quarter
Receive News & Ratings for genedrive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for genedrive and related companies with MarketBeat.com's FREE daily email newsletter.
